GB201401806D0 - Novel methods for diagnosis and therapy - Google Patents

Novel methods for diagnosis and therapy

Info

Publication number
GB201401806D0
GB201401806D0 GBGB1401806.3A GB201401806A GB201401806D0 GB 201401806 D0 GB201401806 D0 GB 201401806D0 GB 201401806 A GB201401806 A GB 201401806A GB 201401806 D0 GB201401806 D0 GB 201401806D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
therapy
novel methods
novel
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1401806.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lyfstone AS
Original Assignee
Orthogenics AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogenics AS filed Critical Orthogenics AS
Priority to GBGB1401806.3A priority Critical patent/GB201401806D0/en
Publication of GB201401806D0 publication Critical patent/GB201401806D0/en
Priority to KR1020167023016A priority patent/KR102511209B1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
GBGB1401806.3A 2014-01-23 2014-02-03 Novel methods for diagnosis and therapy Ceased GB201401806D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1401806.3A GB201401806D0 (en) 2014-02-03 2014-02-03 Novel methods for diagnosis and therapy
KR1020167023016A KR102511209B1 (en) 2014-01-23 2015-01-19 Benzimidazole derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1401806.3A GB201401806D0 (en) 2014-02-03 2014-02-03 Novel methods for diagnosis and therapy

Publications (1)

Publication Number Publication Date
GB201401806D0 true GB201401806D0 (en) 2014-03-19

Family

ID=50344296

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1401806.3A Ceased GB201401806D0 (en) 2014-01-23 2014-02-03 Novel methods for diagnosis and therapy

Country Status (2)

Country Link
KR (1) KR102511209B1 (en)
GB (1) GB201401806D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3182245A1 (en) * 2020-06-12 2021-12-16 Jae Hee Cheon Pharmaceutical composition comprising benzimidazole derivative compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2226315A4 (en) * 2007-12-28 2012-01-25 Carna Biosciences Inc 2-aminoquinazoline derivative
WO2012044090A2 (en) * 2010-09-29 2012-04-05 크리스탈지노믹스(주) Novel aminoquinazoline compound having a protein-kinase inhibiting action

Also Published As

Publication number Publication date
KR102511209B1 (en) 2023-03-17
KR20160104730A (en) 2016-09-05

Similar Documents

Publication Publication Date Title
SI3132034T1 (en) Therapeutic
IL250387A0 (en) Combination therapy
HK1215864A1 (en) Cannula for catgut-embedding therapy
SG11201701035SA (en) Cancer diagnosis and therapy
GB201405033D0 (en) Combination therapy
GB201413357D0 (en) Antibodies for treatment and diagnosis
ZA201702522B (en) Combination therapy
GB201410216D0 (en) Therapeutic
IL250699A0 (en) Medical procedure simulator
IL247325A0 (en) Therapeutic methods employing noribogaine and related compounds
GB201510637D0 (en) Therapeutic
IL250553B (en) Means and methods for targeted x-ray therapy
ZA201608217B (en) Combination therapy
GB201510676D0 (en) Novel diagnostic and therapeutic method
GB201401806D0 (en) Novel methods for diagnosis and therapy
GB201414542D0 (en) Novel therapy
GB201501202D0 (en) Novel methods for diagnosis and therapy
GB201411570D0 (en) Therapy
GB201408210D0 (en) Therapy
GB201418508D0 (en) Therapeutic
GB201419311D0 (en) Combination therapy
GB201413719D0 (en) Therapeutic
GB201410832D0 (en) Therapeutic
GB201410334D0 (en) Therapeutic
GB201406674D0 (en) Therapeutic

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)